GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (LTS:0A8L) » Definitions » Price-to-Free-Cash-Flow

OpGen (LTS:0A8L) Price-to-Free-Cash-Flow : N/A (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is OpGen Price-to-Free-Cash-Flow?

As of today (2024-05-21), OpGen's share price is $5.087. OpGen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-39.31. Hence, OpGen's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for OpGen's Price-to-Free-Cash-Flow or its related term are showing as below:

LTS:0A8L's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.75
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

OpGen's Free Cash Flow per Share for the three months ended in Sep. 2023 was $-3.45. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-39.31.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 60.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 66.80% per year.

During the past 10 years, OpGen's highest 3-Year average Free Cash Flow per Share Growth Rate was 78.50% per year. The lowest was 60.90% per year. And the median was 71.60% per year.


OpGen Price-to-Free-Cash-Flow Historical Data

The historical data trend for OpGen's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OpGen Price-to-Free-Cash-Flow Chart

OpGen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OpGen Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OpGen's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, OpGen's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OpGen's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where OpGen's Price-to-Free-Cash-Flow falls into.



OpGen Price-to-Free-Cash-Flow Calculation

OpGen's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=5.087/-39.314
=N/A

OpGen's Share Price of today is $5.087.
OpGen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

OpGen  (LTS:0A8L) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


OpGen Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of OpGen's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


OpGen (LTS:0A8L) Business Description

Traded in Other Exchanges
Address
9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

OpGen (LTS:0A8L) Headlines

No Headlines